ALXP
ALMIB
Market cap29mUSD
Oct 28, Last price
0.27EUR
1D
-6.90%
1Q
-60.87%
Jan 2017
-98.95%
IPO
-96.98%
Name
Amoeba SA
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
57.80%
Shs. 5Y
—
Rev. 5Y
-3.04%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-8m
CFO
-6m
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Amoéba S.A. focuses on the development and commercialization of anti-microbial and anti-fungal products. The company's primary innovation centers on harnessing the unique properties of the Willaertia magna C2c Maky amoeba, which it is applying across various fields. These applications are designed to mitigate biological risks in critical areas like water purification, the treatment of human injuries, and safeguarding agricultural crops. Established in 2010, Amoéba S.A. is based in Chassieu, France.
Key people
Jean-francois Doucet
Chief Executive Officer · since 2024
Valerie Filiatre
Director · since 2023
Jean-luc Souche Francais
Director · since 2023
Jean-Marc Petat
Director · since 2024
Benoit Villers
Chairman of the Board · since 2023
Philippe Dujardin
Independent Director · since 2021
Pierre Morgon French
Independent Director · since 2021
Sylvie Guinard
Independent Director · since 2022
Headquarters & legal address
38 AVENUE DES FRERES MONTGOLFIER
CHASSIEU 69680
FR
CHASSIEU 69680
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |